NovaSight Announces First-Ever Pivotal Study for Lazy-Eye Digital Treatment Against Gold Standard Patching
NovaSight has announced that it is running a large, pivotal multi-center randomized controlled trial to assess the safety and effectiveness of an eye-tracking-based treatment for Amblyopia (Lazy Eye).